Medicover has signed a new EUR 450 million syndicated revolving credit facility agreement. The facility has a maturity of three years with two one-year extension options subject to lenders' approval. The new facility replaces the existing EUR 300 million revolving credit facility dated June 2022.
The facility was oversubscribed and successfully syndicated with nine participating banks, reflecting confidence in Medicover and the company's continuous strong growth and positive long-term outlook.
Nordea acted as the Coordinating Bookrunner and Mandated Lead Arranger, Documentation Agent and Facility Agent. Erste Bank Polska, ING, Landesbank Hessen-Thüringen, Raiffeisen and SEB acted as Bookrunners and Mandated Lead Arranger. Bank Pekao, Oldenburgische Landesbank and UniCredit acted as Mandated Lead Arranger.
For further information, please contact:
Hanna Bjellquist, Head of Investor Relations
+46 703 033 272
hanna.bjellquist@medicover.com
About Us
Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities, laboratories and blood-drawing points and the largest markets are Poland, Germany, Romania and India. In 2025, Medicover had revenue of €2,378 million and more than 49,000 employees. For more information, go to www.medicover.com
